A3P

Log in

Discovery of an effective antibiotic against resistant bacteria

Scientists have discovered in a soil sample taken in Italy a new antibiotic, which is effective against bacteria resistant to known antimicrobials.

Read more...

Ipsen treatment gets a new indication in the US

Dysport, a drug of the French pharmaceutical group Ipsen against spasticity, now enjoys a new marketing authorization in the United States to treat the lower limbs in adults, the group said Friday.

Read more...

ANSM plans to "restrict access" to codein drugs

The Medicines Agency (ANSM) is considering ways to "restrict access" to drugs containing codeine, in the face of increased use diversions, especially among teenagers, said one of its leaders .

Read more...

Sanofi wants to become a champion of bioproduction drugs

Sanofi has lately embraced the biotechnological revolution, but is accelerating to catch up: after 3,3 billion of industrial investments in this field in the last five years, it plans to spend about 600 million euros per year by 2020.

Read more...

Pharmaceutical subcontracting: P & B takes over Laboratories Richard and saves 53 jobs

The subcontractor for the pharmaceutical and cosmetics industries P & B Group will resume at the bar of the commercial court its competitor Richard Laboratories, saving its 53 jobs, said Thursday its president Laurent Dodet.

Read more...

a3p-100pxhaut logo

 fren

Commit to share
Transmit and progress together
Promoting innovation

The A3P Association is a major player in the pharmaceutical and biotechnology industry.
Created in 1986, it contributes to the good development of the production of medicines and clean and sterile equipment, it runs a network of professionals 21 000, manufacturers and suppliers, as part of International Congress and technical days.

It now has over 1700 members who share their technical experience, scientific and regulatory.

More info on video (Versiongb here )


  group    administrators A3P
    
& Project Managers

letter   newsletter A3P